Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Improving the quality of clinical pharmacy services: a process to identify and capture high-value "quality actions".

Literature DB >> 22479028

Improving the quality of clinical pharmacy services: a process to identify and capture high-value "quality actions".

Nicole Bruchet¹, Peter Loewen, Jane de Lemos.

Abstract

Year: 2011 PMID： 22479028 PMCID： PMC3053192 DOI： 10.4212/cjhp.v64i1.986

Source DB: PubMed Journal: Can J Hosp Pharm ISSN： 0008-4123

× No keyword cloud information.

18 in total

1. Defining and classifying clinical indicators for quality improvement.

Authors: Jan Mainz
Journal: Int J Qual Health Care Date: 2003-12 Impact factor: 2.038

2. Effect of the transformation of the Veterans Affairs Health Care System on the quality of care.

Authors: Ashish K Jha; Jonathan B Perlin; Kenneth W Kizer; R Adams Dudley
Journal: N Engl J Med Date: 2003-05-29 Impact factor: 91.245

3. An intervention to decrease catheter-related bloodstream infections in the ICU.

Authors: Peter Pronovost; Dale Needham; Sean Berenholtz; David Sinopoli; Haitao Chu; Sara Cosgrove; Bryan Sexton; Robert Hyzy; Robert Welsh; Gary Roth; Joseph Bander; John Kepros; Christine Goeschel
Journal: N Engl J Med Date: 2006-12-28 Impact factor: 91.245

4. Implementation of proven interventions in general medical inpatients: development and evaluation of a new quality indicator for drug therapy.

Authors: C Huang; P Loewen; T Pelletier; J Slater; M Chung
Journal: Qual Saf Health Care Date: 2008-08

5. Opportunities and responsibilities in pharmaceutical care.

Authors: C D Hepler; L M Strand
Journal: Am J Hosp Pharm Date: 1990-03

6. Identifying missed opportunities to curtail antimicrobial therapy for presumed ventilator-associated pneumonia using the clinical pulmonary infection score.

Authors: Sean K Gorman; Lynne-Michelle M Stewart; Richard S Slavik; Jane de Lemos; Dean Chittock; Vinay K Dhingra; Juan J Ronco; Harjinder Parwana
Journal: Can J Hosp Pharm Date: 2009-05

7. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure.

Authors: J N Cohn; G Johnson; S Ziesche; F Cobb; G Francis; F Tristani; R Smith; W B Dunkman; H Loeb; M Wong
Journal: N Engl J Med Date: 1991-08-01 Impact factor: 91.245

8. Sins of omission: getting too little medical care may be the greatest threat to patient safety.

Authors: Rodney A Hayward; Steven M Asch; Mary M Hogan; Timothy P Hofer; Eve A Kerr
Journal: J Gen Intern Med Date: 2005-08 Impact factor: 5.128

9. Drug-related problems: their structure and function.

Authors: L M Strand; P C Morley; R J Cipolle; R Ramsey; G D Lamsam
Journal: DICP Date: 1990-11

10. Capturing outcomes of clinical activities performed by a rounding pharmacist practicing in a team environment: the COLLABORATE study [NCT00351676].

Authors: Mark J Makowsky; Sheri L Koshman; William K Midodzi; Ross T Tsuyuki
Journal: Med Care Date: 2009-06 Impact factor: 2.983

5 in total

Improving the quality of clinical pharmacy services: a process to identify and capture high-value "quality actions".

1. Defining and classifying clinical indicators for quality improvement.

2. Effect of the transformation of the Veterans Affairs Health Care System on the quality of care.

3. An intervention to decrease catheter-related bloodstream infections in the ICU.

4. Implementation of proven interventions in general medical inpatients: development and evaluation of a new quality indicator for drug therapy.

5. Opportunities and responsibilities in pharmaceutical care.

6. Identifying missed opportunities to curtail antimicrobial therapy for presumed ventilator-associated pneumonia using the clinical pulmonary infection score.

7. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure.

8. Sins of omission: getting too little medical care may be the greatest threat to patient safety.

9. Drug-related problems: their structure and function.

10. Capturing outcomes of clinical activities performed by a rounding pharmacist practicing in a team environment: the COLLABORATE study [NCT00351676].

1. Should Hospital Pharmacists Provide Postdischarge Follow-Up Care to High-Risk Patients?

2. Pharmacist Clinical Process Improvement: Applying Lean Principles in a Tertiary Care Setting.

3. Should key performance indicators be a component of performance assessment for individual clinical pharmacists?

4. Clinical Pharmacy Activities: We Know What to Do, but for Whom Should We Do It?

5. Development of a tool for benchmarking of clinical pharmacy activities.